Alcoholic liver disease: Treatment

被引:55
作者
Suk, Ki Tae [1 ]
Kim, Moon Young [2 ]
Baik, Soon Koo [2 ]
机构
[1] Hallym Univ, Coll Med, Dept Internal Med, Chunchon 200704, South Korea
[2] Yonsei Univ, Wonju Severance Christian Hosp, Wonju Coll Med, Dept Internal Med, Wonju 220701, South Korea
关键词
Liver disease; Alcoholic; Treatment; SHORT-TERM SURVIVAL; PROTEIN-CALORIE MALNUTRITION; RANDOMIZED CONTROLLED-TRIAL; DE-NOVO MALIGNANCIES; AND/OR HEPATITIS-B; DOUBLE-BLIND; FATTY LIVER; NUTRITIONAL SUPPORT; ENTERAL NUTRITION; RETROSPECTIVE ANALYSIS;
D O I
10.3748/wjg.v20.i36.12934
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The excess consumption of alcohol is associated with alcoholic liver diseases (ALD). ALD is a major healthcare problem, personal and social burden, and significant reason for economic loss worldwide. The ALD spectrum includes alcoholic fatty liver, alcoholic hepatitis, cirrhosis, and the development of hepatocellular carcinoma. The diagnosis of ALD is based on a combination of clinical features, including a history of significant alcohol intake, evidence of liver disease, and laboratory findings. Abstinence is the most important treatment for ALD and the treatment plan varies according to the stage of the disease. Various treatments including abstinence, nutritional therapy, pharmacological therapy, psychotherapy, and surgery are currently available. For severe alcoholic hepatitis, corticosteroid or pentoxifylline are recommended based on the guidelines. In addition, new therapeutic targets are being under investigation. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:12934 / 12944
页数:11
相关论文
共 129 条
  • [1] Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study
    Addolorato, Giovanni
    Leggio, Lorenzo
    Ferrulli, Anna
    Cardone, Silvia
    Vonghia, Luisa
    Mirijello, Antonio
    Abenavoli, Ludovico
    D'Angelo, Cristina
    Caputo, Fabio
    Zambon, Antonella
    Haber, Paul S.
    Gasbarrini, Giovanni
    [J]. LANCET, 2007, 370 (9603) : 1915 - 1922
  • [2] Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient - A case report
    Agabio, Roberta
    Marras, Priamo
    Addolorato, Giovanni
    Carpiniello, Bernardo
    Gessa, Gian Luigi
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 319 - 320
  • [3] Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
    Akiyama, Kentaro
    Chen, Chider
    Wang, DanDan
    Xu, Xingtian
    Qu, Cunye
    Yamaza, Takayoshi
    Cai, Tao
    Chen, WanJun
    Sun, Lingyun
    Shi, Songtao
    [J]. CELL STEM CELL, 2012, 10 (05) : 544 - 555
  • [4] Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    Akriviadis, E
    Botla, R
    Briggs, W
    Han, S
    Reynolds, T
    Shakil, O
    [J]. GASTROENTEROLOGY, 2000, 119 (06) : 1637 - 1648
  • [5] [Anonymous], 2011, The global status report on alcohol and health
  • [6] [Anonymous], KOREAN J HEPATOL
  • [7] [Anonymous], 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002800
  • [8] [Anonymous], HEPAT MON
  • [9] Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo
    Aurich, H.
    Sgodda, M.
    Kaltwasser, P.
    Vetter, M.
    Weise, A.
    Liehr, T.
    Brulport, M.
    Hengstler, J. G.
    Dollinger, M. M.
    Fleig, W. E.
    Christ, B.
    [J]. GUT, 2009, 58 (04) : 570 - 581
  • [10] BRIEF INTERVENTIONS FOR ALCOHOL-PROBLEMS - A REVIEW
    BIEN, TH
    MILLER, WR
    TONIGAN, JS
    [J]. ADDICTION, 1993, 88 (03) : 315 - 336